IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling

References

• Adams LA, Sanderson S, Lindor KD, Angulo P. (2005). The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42:132–38.
   PubMed Web of Science ®Google Scholar
• Angulo P, Lindor KD. (2002). Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 Suppl:S186–90.
   PubMed Web of Science ®Google Scholar
• Aoki N, Matsuda T. (2000). A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J Biol Chem 275:39718–26.
   PubMedGoogle Scholar
• Araki E, Lipes MA, Patti ME, Brüning JC, Haag G 3rd, Johnson RS, Kahn CR. (1994). Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–90.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Saito K, Ait-Goughoulte M, Meyer K, Ray RB, Ray R. (2008). Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signalling pathway for insulin resistance. J Virol 82:2606–12.
   PubMed Web of Science ®Google Scholar
• Bentires-Alj M, Neel BG. (2007). Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res 67:2420–24.
   PubMed Web of Science ®Google Scholar
• Bourdeau A, Dube N, Tremblay ML. (2005). Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 17:203–9.
   PubMedGoogle Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–68.
   PubMed Web of Science ®Google Scholar
• Buckley DA, Cheng A, Kiely PA, Tremblay ML, O’Connor R (2002) Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol Cell Biol 22:1998–2010.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, McCullough AJ, Marchesini G. (2005). Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42:987–1000.
   PubMed Web of Science ®Google Scholar
• Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ. (2003a). Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38:1188–98.
   PubMed Web of Science ®Google Scholar
• Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. (2003b). Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83:655–63.
   PubMed Web of Science ®Google Scholar
• Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF. (2002). Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277:28795–802.
   PubMed Web of Science ®Google Scholar
• Clampit JE, Meuth JL, Smith HT, Reilly RM, Jirousek MR, Trevillyan JM, Rondinone CM. (2003). Reduction of protein-tyrosine phosphatase-1B increases insulin signalling in FAO hepatoma cells. Biochem Biophys Res Commun 300:261–7.
   PubMed Web of Science ®Google Scholar
• Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. (2001). Insulin resistance and a diabetes mellitus–like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–31.
   PubMed Web of Science ®Google Scholar
• Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A. (2003). Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52:642–9.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. (2004). Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787–835, ix.
   PubMed Web of Science ®Google Scholar
• Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, Bence KK. (2009). Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58:590–99.
   PubMed Web of Science ®Google Scholar
• Dong XC, Copps KD, Guo S, Li Y, Kollipara R, DePinho RA, White MF. (2008). Inactivation of hepatic Foxo1 by insulin signalling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65–76.
   PubMed Web of Science ®Google Scholar
• Dube N, Bourdeau A, Heinonen KM, Cheng A, Loy AL, Tremblay ML. (2005). Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development. Cancer Res 65:10088–95.
   PubMed Web of Science ®Google Scholar
• Egawa K, Maegawa H, Shimitzu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A. (2001). Protein-tyrosine phosphatase-1B negatively regulates insulin signalling in l6 myocytes and Fao hepatoma cells. J Biol Chem 276:10207–11.
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548
   PubMed Web of Science ®Google Scholar
• Escriva F, Gonzalez-Rodriguez A, Fernandez-Millan E, Rondinone CM, Alvarez C, Valverde AM (2010). PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I. J Cell Physiol 225:214–22.
   PubMed Web of Science ®Google Scholar
• Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG, HALT-C Trial Group. (2009). Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology 137:549–57.
   PubMed Web of Science ®Google Scholar
• Farrell GC, Larter CZ. (2006). Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112
   PubMed Web of Science ®Google Scholar
• Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. (2003) Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125:437–43.
   PubMed Web of Science ®Google Scholar
• Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belifiore A, Vigneri R. (1999) Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278–88.
   PubMed Web of Science ®Google Scholar
• Friedman SL. (2008). Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655–69.
   PubMed Web of Science ®Google Scholar
• Garcia-Monzon C, Lo Iacono O, Mayoral R, González-Rodríguez A, Miquilena-Colina ME, Lozano-Rodríguez T, García-Pozo L, Vargas-Castrillón J, Casado M, Boscá L, et al. (2011). Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. J Hepatol 54:142–52.
   PubMed Web of Science ®Google Scholar
• Goldstein BJ. (2001). Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Curr Drug Targets Immune Endocr Metabol Disord 1:265–75.
   PubMedGoogle Scholar
• Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM, Valverde AM. (2007a). Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. Endocrinology 148:594–608.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez A, Escribano O, Alba J, Rondinone CM, Benito M, Valverde AM. (2007b). Levels of protein tyrosine phosphatase 1B determine susceptibility to apoptosis in serum-deprived hepatocytes. J Cell Physiol 212:76–88.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez A, Mas Gutierrez JA, Sanz-Gonzalez S, Ros M, Burks DJ, Valverde AM. (2010). Inhibition of PTP1B restores IRS1-mediated hepatic insulin signalling in IRS2-deficient mice. Diabetes 59:588–599.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez A, Nevado C, Escrivá F, Sesti G, Rondinone CM, Benito M, Valverde AM. (2008). PTP1B deficiency increases glucose uptake in neonatal hepatocytes: involvement of IRA/GLUT2 complexes. Am J Physiol Gastrointest Liver Physiol 295:G338–347
   PubMed Web of Science ®Google Scholar
• Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA, Trevillyan JM, Ulrich RG, Jirousek MR, Rondinone CM. (2003). Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signalling in ob/ob mice. Diabetes 52:21–8.
   PubMed Web of Science ®Google Scholar
• Haj FG, Zabolotny JM, Kim YB, Kahn BB, Neel BG (2005) Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice. J Biol Chem 280:15038–46.
   PubMed Web of Science ®Google Scholar
• Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O’Brien R, Granner DK. (2000). Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 275:30169–75.
   PubMed Web of Science ®Google Scholar
• Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, et al. (2008). SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283:20015–26.
   PubMed Web of Science ®Google Scholar
• Inada S, Ikeda Y, Suehiro T, Takata H, Osaki F, Arii K, Kumon Y, Hashimoto K. (2007). Glucose enhances protein tyrosine phosphatase 1B gene transcription in hepatocytes. Mol Cell Endocrinol 271:64–70.
   PubMed Web of Science ®Google Scholar
• Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML. (2007). Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet 39:338–46.
   PubMed Web of Science ®Google Scholar
• Kahn SE. (2003). The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46:3–19.
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Machicao F, Machann J, Schick F, Fritsche A, Haering HU, Stefan N. (2009a). The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. Clin Sci (Lond) 116:531–7.
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Koenigsrainer I, Koenigsrainer A, Schick F, Fritsche A, Haering HU, et al. (2009b). Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58:2616–23.
   PubMed Web of Science ®Google Scholar
• Kasibhatla B, Wos J, Peters KG. (2007). Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes. Curr Opin Investig Drugs 8:805–13.
   PubMed Web of Science ®Google Scholar
• Kasuga M, Karlsson FA, Kahn CR. (1982). Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215:185–7.
   PubMed Web of Science ®Google Scholar
• Kipfer-Coudreau S, Eberle D, Sahbatou M, Bonhomme A, Guy-Grand B, Froguel P, Galan P, Basdevant A, Clement K. (2004). Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia 47:1278–84.
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–89.
   PubMed Web of Science ®Google Scholar
• Kubota N, Kubota T, Itoh S, Kumagai H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M, Sasako T, et al. (2008). Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signalling during fasting and feeding. Cell Metab 8:49–64.
   PubMed Web of Science ®Google Scholar
• Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, et al. (2000). Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880–89.
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. (1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–39.
   PubMed Web of Science ®Google Scholar
• Kushner JA et al. (2004). Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes 53:61–6.
   PubMed Web of Science ®Google Scholar
• Larter CZ, Farrell GC. (2006). Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? J Hepatol 44:253–61.
   PubMed Web of Science ®Google Scholar
• Lauer GM, Walker BD. (2001). Hepatitis C virus infection. N Engl J Med 345:41–52.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCollough AJ, Natale S, Forlani G, Melchionda N. (2001). Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–50.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, et al. (2003). Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–23.
   PubMed Web of Science ®Google Scholar
• Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurte E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, et al.. (2009) Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137:532–40.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Yano Y, Gabazza EC, Araki R, Bruno NE, Suematsu M, Akatsuka H, Katsuki A, Taguchi O, Adachi Y, et al. (2007). Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients. Diabet Med 24:1322–8.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Matsumoto M, Ogawa W, Teshigawara K, Inoue H, Miyake K, Sakaue H, Kasuga M.. (2002). Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signalling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51:1672–80.
   PubMed Web of Science ®Google Scholar
• Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV Sr, et al. (2007). Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6:69–78.
   PubMed Web of Science ®Google Scholar
• Morino K, Petersen KF, Shulman GI. (2006). Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 Suppl 2:S9–15.
   PubMed Web of Science ®Google Scholar
• Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Marinot-Pergnoux M, Maylin S, Nicolas-Chanoine MH, et al. (2008). Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134:416–23.
   PubMed Web of Science ®Google Scholar
• Nakae J, Biggs WH 3rd, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D. (2002). Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245–53.
   PubMed Web of Science ®Google Scholar
• Nakae J, Kitamura T, Silver DL, Accili D. (2001). The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359–67.
   PubMed Web of Science ®Google Scholar
• Navarro P, Valverde AM, Benito M, Lorenzo M. (1998). Insulin/IGF-I rescues immortalized brown adipocytes from apoptosis down-regulating Bcl-xS expression, in a PI 3-kinase- and map kinase-dependent manner. Exp Cell Res 243:213–21.
   PubMed Web of Science ®Google Scholar
• Nevado C, Valverde AM, Benito M. (2006). Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology 147:3709–18.
   PubMed Web of Science ®Google Scholar
• Pauli JR, Ropelle ER, Cintra DE, De Souza CT, da Silva AS, Moraes JC, Prada PO, de Almeida Leme JA, Luciano E, Velloso LA, et al. (2010). Acute exercise reverses aged-induced impairments in insulin signalling in rodent skeletal muscle. Mech Ageing Dev 131:323–9.
   PubMed Web of Science ®Google Scholar
• Previs SF, Withers DJ, Ren JM, White MF, Shulman GI. (2000). Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275:38990–94.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, et al. (2003). Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550–55.
   PubMed Web of Science ®Google Scholar
• Reaven GM. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607.
   PubMed Web of Science ®Google Scholar
• Romero-Gomez M, Del Mar Viloria M, Andrade RJ, Salmeron J, Diago M, Fernandez-Rodriguez CM, Corpas R, Cruz M, Grande L, Vazquez L, et al. (2005). Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128:636–41.
   PubMed Web of Science ®Google Scholar
• Samuel VT, Liu ZX, Qu X, Elder BD, Bliz S, Befroy D, Romanelli AJ, Shulman GI. (2004). Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345–53.
   PubMed Web of Science ®Google Scholar
• Sangwan V, Paliouras GN, Cheng A, Dube N, Tremblay ML, Park M. (2006). Protein-tyrosine phosphatase 1B deficiency protects against Fas-induced hepatic failure. J Biol Chem 281:221–8.
   Google Scholar
• Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG. (2000). Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem 275:36324–33.
   PubMed Web of Science ®Google Scholar
• Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, Moriya K, Koike K. (2004). Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126:840–48.
   PubMed Web of Science ®Google Scholar
• Simmgen M, Knauf C, Lopez M, Choudhury AI, Charalambous M, Cantley J, Bedford DC, Claret M, Iglesias MA, Heffron H, et al. (2006). Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice. Diabetologia 49:552–61.
   PubMed Web of Science ®Google Scholar
• Solinas G, Naugler W, Galimi F, Lee MS, Karin M. (2006). Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci USA 103:16454–9.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q. (2007). SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307–19.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, Friedman JE. (2002). Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signalling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277:23301–7.
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A, et al. (1999). Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 29:1743–51.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. (2006). Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85–96.
   PubMed Web of Science ®Google Scholar
• Valenti L, Rametta R, Dongiovanni P, Maggioni M, Fracanzani AL, Zappa M, Lattuada E, Roviaro G, Fargion S. (2008). Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57:1355–62.
   PubMed Web of Science ®Google Scholar
• Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF, Benito M. (2003). Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52:2239–48.
   PubMed Web of Science ®Google Scholar
• Valverde AM, Fabregat I, Burks DJ, White MF, Benito M. (2004). IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes. Hepatology 40:1285–94.
   PubMed Web of Science ®Google Scholar
• Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE. (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 39:1230–38.
   PubMed Web of Science ®Google Scholar
• White MF. (2006). Regulating insulin signalling and beta-cell function through IRS proteins. Can J Physiol Pharmacol 84:725–37.
   PubMed Web of Science ®Google Scholar
• Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. (1999). Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 23:32–40.
   PubMed Web of Science ®Google Scholar
• Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–4.
   PubMed Web of Science ®Google Scholar
• Xuan S, Kitamura T, Nakae J, Politi K, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, et al. (2002). Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest 110:1011–19.
   PubMed Web of Science ®Google Scholar
• Xue B, Kim YB, Lee A, Toschi E, Bonner-Weir S, Kahn CR, Neel BG, Kahn BB. (2007). Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem 282:23829–40.
   PubMed Web of Science ®Google Scholar
• Yoon JW, Jun HS. (2001). Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann NY Acad Sci 928:200–11.
   PubMed Web of Science ®Google Scholar
• Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB. (2008). Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 283:14230–41.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang J, Guo Y, Ye H, Yu C, Xu C, Xu L, Wu S, Sun W, Wei H, et al. (2010). Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Hepatology 51:1190–99.
   PubMed Web of Science ®Google Scholar
• Zhu S, Bjorge JD, Fujita DJ. (2007). PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res 67:10129–37.
   PubMed Web of Science ®Google Scholar